Human Clinical Trials - NMN
Below is the complete list of human clinical trails for NMN to date.
As you can see, the frequency of trials in the past year has greatly increased due to public interest and potential therapeutic applications.
#
Year
Dose
Title
17
2023
250mg
16
2023
250mg
15
2023
2,000mg
14
2022
300mg
600mg
900mg
13
2022
250mg
12
2022
300mg
11
2022
1,250mg
10
2022
250mg
9
2022
300mg
FOCUS AREA
BIOMARKERS
EFFICACY
8
2022
250mg
7
2022
300mg
6
2022
250mg
FOCUS AREA
WOMEN
5
2022
250mg
4
2022
250mg
3
2022
1,000mg
2
2021
1,200mg
Why do we ship from Hong Kong and not Australia?
It's a great question and we aim for 100% transparency in everything we do.
The reason is NMN is currently not yet approved by the TGA for sale within Australia. NMN is only approved by the TGA for export use only.
That means local Australian businesses cannot legally sell NMN to Australian consumers either from within or outside the country.
You may see some competitors selling locally but please note, they are not legally approved to do so.
For this reason, since all NMN is produced in China anyway, we ship out of Hong Kong to keep our costs competitive and shipping times low.
All our NMN is has been third-party tested by an independent US lab for purity.
We have faith the TGA will at some point authorise its distribution within Australia, but as you might imagine, governmental regulatory bodies must, by their very nature, lag behind scientific advancements.
We appreciate your understanding and if you have any questions at all, don't hesitate to contact us at hello@agemate.com.